[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Ophthalmology Drugs Market Report 2017

November 2017 | 104 pages | ID: U97939D9268WEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Ophthalmology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Ophthalmology Drugs in these regions, from 2012 to 2022 (forecast).
United States Ophthalmology Drugs market competition by top manufacturers/players, with Ophthalmology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis
  • Regeneron
  • Roche
  • Bayer
  • Allergan
  • Shire
  • Mallinckrodt
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Lucentis (ranibizumab)
  • Eylea (aflibercept)
  • Avastin (bevacizumab)
  • Restasis (cyclosporine)
  • Alphagan (brimonidine tartrate)
  • Lumigan (bimatoprost)
  • Xalatan (latanoprost
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Chorioretinitis
  • Choroiditis
  • Retinitis
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Ophthalmology Drugs Market Report 2017

1 OPHTHALMOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Ophthalmology Drugs
1.2 Classification of Ophthalmology Drugs by Product Category
  1.2.1 United States Ophthalmology Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ophthalmology Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Lucentis (ranibizumab)
  1.2.4 Eylea (aflibercept)
  1.2.5 Avastin (bevacizumab)
  1.2.6 Restasis (cyclosporine)
  1.2.7 Alphagan (brimonidine tartrate)
  1.2.8 Lumigan (bimatoprost)
  1.2.9 Xalatan (latanoprost
1.3 United States Ophthalmology Drugs Market by Application/End Users
  1.3.1 United States Ophthalmology Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chorioretinitis
  1.3.3 Choroiditis
  1.3.4 Retinitis
  1.3.5 Others
1.4 United States Ophthalmology Drugs Market by Region
  1.4.1 United States Ophthalmology Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.5 New England Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.6 The South Ophthalmology Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Ophthalmology Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ophthalmology Drugs (2012-2022)
  1.5.1 United States Ophthalmology Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Ophthalmology Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES OPHTHALMOLOGY DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ophthalmology Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ophthalmology Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ophthalmology Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Ophthalmology Drugs Market Competitive Situation and Trends
  2.4.1 United States Ophthalmology Drugs Market Concentration Rate
  2.4.2 United States Ophthalmology Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ophthalmology Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPHTHALMOLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ophthalmology Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Ophthalmology Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Ophthalmology Drugs Price by Region (2012-2017)

4 UNITED STATES OPHTHALMOLOGY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ophthalmology Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ophthalmology Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Ophthalmology Drugs Price by Type (2012-2017)
4.4 United States Ophthalmology Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OPHTHALMOLOGY DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ophthalmology Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Ophthalmology Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPHTHALMOLOGY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmology Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Regeneron
  6.2.2 Ophthalmology Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Regeneron Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche
  6.3.2 Ophthalmology Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.2 Ophthalmology Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.2 Ophthalmology Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shire
  6.6.2 Ophthalmology Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shire Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Mallinckrodt
  6.7.2 Ophthalmology Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Mallinckrodt Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 OPHTHALMOLOGY DRUGS MANUFACTURING COST ANALYSIS

7.1 Ophthalmology Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmology Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPHTHALMOLOGY DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ophthalmology Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ophthalmology Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Ophthalmology Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Ophthalmology Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Ophthalmology Drugs
Figure United States Ophthalmology Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Ophthalmology Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Lucentis (ranibizumab) Product Picture
Figure Eylea (aflibercept) Product Picture
Figure Avastin (bevacizumab) Product Picture
Figure Restasis (cyclosporine) Product Picture
Figure Alphagan (brimonidine tartrate) Product Picture
Figure Lumigan (bimatoprost) Product Picture
Figure Xalatan (latanoprost Product Picture
Figure United States Ophthalmology Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Ophthalmology Drugs by Application in 2016
Figure Chorioretinitis Examples
Table Key Downstream Customer in Chorioretinitis
Figure Choroiditis Examples
Table Key Downstream Customer in Choroiditis
Figure Retinitis Examples
Table Key Downstream Customer in Retinitis
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Ophthalmology Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ophthalmology Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Ophthalmology Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Ophthalmology Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmology Drugs Sales Share by Players/Suppliers
Figure 2017 United States Ophthalmology Drugs Sales Share by Players/Suppliers
Figure United States Ophthalmology Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ophthalmology Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ophthalmology Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ophthalmology Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Ophthalmology Drugs Revenue Share by Players/Suppliers
Table United States Market Ophthalmology Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Ophthalmology Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Ophthalmology Drugs Market Share of Top 3 Players/Suppliers
Figure United States Ophthalmology Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ophthalmology Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ophthalmology Drugs Product Category
Table United States Ophthalmology Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Ophthalmology Drugs Sales Share by Region (2012-2017)
Figure United States Ophthalmology Drugs Sales Share by Region (2012-2017)
Figure United States Ophthalmology Drugs Sales Market Share by Region in 2016
Table United States Ophthalmology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ophthalmology Drugs Revenue Share by Region (2012-2017)
Figure United States Ophthalmology Drugs Revenue Market Share by Region (2012-2017)
Figure United States Ophthalmology Drugs Revenue Market Share by Region in 2016
Table United States Ophthalmology Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Ophthalmology Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Ophthalmology Drugs Sales Share by Type (2012-2017)
Figure United States Ophthalmology Drugs Sales Share by Type (2012-2017)
Figure United States Ophthalmology Drugs Sales Market Share by Type in 2016
Table United States Ophthalmology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ophthalmology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ophthalmology Drugs by Type (2012-2017)
Figure Revenue Market Share of Ophthalmology Drugs by Type in 2016
Table United States Ophthalmology Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Ophthalmology Drugs Sales Growth Rate by Type (2012-2017)
Table United States Ophthalmology Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Ophthalmology Drugs Sales Market Share by Application (2012-2017)
Figure United States Ophthalmology Drugs Sales Market Share by Application (2012-2017)
Figure United States Ophthalmology Drugs Sales Market Share by Application in 2016
Table United States Ophthalmology Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Ophthalmology Drugs Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Novartis Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Regeneron Basic Information List
Table Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Regeneron Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Regeneron Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Regeneron Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Roche Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Roche Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Bayer Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Allergan Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Shire Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Shire Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Sales Growth Rate (2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Sales Market Share in United States (2012-2017)
Figure Mallinckrodt Ophthalmology Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmology Drugs
Figure Manufacturing Process Analysis of Ophthalmology Drugs
Figure Ophthalmology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmology Drugs Major Players/Suppliers in 2016
Table Major Buyers of Ophthalmology Drugs
Table Distributors/Traders List
Figure United States Ophthalmology Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ophthalmology Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Ophthalmology Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Ophthalmology Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ophthalmology Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories